Abstract
The objective of this study is to utilize the pH sensitivity of modified mesoporous silica nanoparticles (MSN) for oral delivery of insulin. Activated silica nanoparticle was modified first with different densities of 3- Chloropropyltrimethoxysilane (3-CTMS) to load the Chlor group which will bond with the organic functional group contained in 4-hydroxybenzoic acid (4-HBA). The nanoparticles were characterized by FTIR and SEM. Equilibrium swelling studies were carried out in enzyme-free simulated gastric and intestinal fluids (SGF and SIF, respectively). Insulin was entrapped in these nanoparticles and the in vitro release profiles were established separately in both (SGF, pH 1) and (SIF, pH 7.4). The amount of loading of insulin was increased with increasing -COO- densities resulting from the increasing number of 4-HBA groups. In these cases, the biological activity of insulin was retained. These results were used to design and improve protein release behavior from these carriers.
Keywords: Silica nanoparticles, 4-hydroxybenzoic acid, pH-sensitive, insulin, oral drug delivery, Activated silica, 3-Chloropropyltrimethoxysilane, in vitro, swelling, release behavior, FTIR, SEM
Current Drug Delivery
Title: Synthesis and Characterization of pH-Sensitive Silica Nanoparticles for Oral-Insulin Delivery
Volume: 8 Issue: 6
Author(s): Mehrdad Mahkam
Affiliation:
Keywords: Silica nanoparticles, 4-hydroxybenzoic acid, pH-sensitive, insulin, oral drug delivery, Activated silica, 3-Chloropropyltrimethoxysilane, in vitro, swelling, release behavior, FTIR, SEM
Abstract: The objective of this study is to utilize the pH sensitivity of modified mesoporous silica nanoparticles (MSN) for oral delivery of insulin. Activated silica nanoparticle was modified first with different densities of 3- Chloropropyltrimethoxysilane (3-CTMS) to load the Chlor group which will bond with the organic functional group contained in 4-hydroxybenzoic acid (4-HBA). The nanoparticles were characterized by FTIR and SEM. Equilibrium swelling studies were carried out in enzyme-free simulated gastric and intestinal fluids (SGF and SIF, respectively). Insulin was entrapped in these nanoparticles and the in vitro release profiles were established separately in both (SGF, pH 1) and (SIF, pH 7.4). The amount of loading of insulin was increased with increasing -COO- densities resulting from the increasing number of 4-HBA groups. In these cases, the biological activity of insulin was retained. These results were used to design and improve protein release behavior from these carriers.
Export Options
About this article
Cite this article as:
Mahkam Mehrdad, Synthesis and Characterization of pH-Sensitive Silica Nanoparticles for Oral-Insulin Delivery, Current Drug Delivery 2011; 8 (6) . https://dx.doi.org/10.2174/156720111797635522
DOI https://dx.doi.org/10.2174/156720111797635522 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
F508del-CFTR Rescue: A Matter of Cell Stress Response
Current Pharmaceutical Design Emerging Biologics in the Treatment of Inflammatory Bowel Disease: What is Around the Corner?
Current Drug Targets Microparticles: A Pivotal Nexus in Vascular Homeostasis and Disease
Current Clinical Pharmacology Glucuronides in Anti-Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Editorial (Thematic Issue: Targeted Therapies in Upper Gastrointestinal Malignancies)
Current Medicinal Chemistry Steatohepatitis in HIV-Infected Subjects: Pathogenesis, Clinical Impact and Implications in Clinical Management
Current HIV Research Klotho-FGF23, Cardiovascular Disease, and Vascular Calcification: Black or White?
Current Vascular Pharmacology Application of Lipidomics to Assess Lipogenesis in Drug Development and Pre-Clinical Trials
Current Pharmaceutical Biotechnology The Mediterranean Diet: A Combination of Beneficial Elements for Cardiovascular Disease
Current Nutrition & Food Science Design of Small Molecules Targeting I-BAR Proteins
Current Pharmaceutical Design Endothelial Cell Senescence and Inflammaging: MicroRNAs as Biomarkers and Innovative Therapeutic Tools
Current Drug Targets Molecular Interaction of Human Brain Acetylcholinesterase with a Natural Inhibitor Huperzine-B: An Enzoinformatics Approach
CNS & Neurological Disorders - Drug Targets Risk Factors Associated with Resistance in CTX-M Producing E. coli Isolates
Current Drug Therapy Clinical Trials for Neuroprotection in ALS
CNS & Neurological Disorders - Drug Targets Arterial Wall Structure and Dynamics in Type 2 Diabetes Mellitus Methodological Aspects and Pathophysiological Findings
Current Diabetes Reviews Advanced Techniques for Penetration Enhancement in Transdermal Drug Delivery System
Current Drug Delivery NAD in Skin: Therapeutic Approaches for Niacin
Current Pharmaceutical Design Progresses and Challenges in Optimization of Human Pluripotent Stem Cell Culture
Current Stem Cell Research & Therapy Aspirin: from a Historical Perspective
Recent Patents on Cardiovascular Drug Discovery Potential Role of Polyphenols in the Prevention of Cardiovascular Diseases: Molecular Bases
Current Medicinal Chemistry